11 – 20 of 47
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma
(
- Contribution to journal › Article
-
Mark
Noninvasive detection of any-stage cancer using free glycosaminoglycans
(
- Contribution to journal › Article
-
Mark
Recurrence pattern in localized RCC : results from a European multicenter database (RECUR)
(
- Contribution to journal › Article
-
Mark
Diagnostic and prognostic factors in patients with prostate cancer : a systematic review
(
- Contribution to journal › Scientific review
-
Mark
Plasma and Urine Free Glycosaminoglycans as Monitoring Biomarkers in Nonmetastatic Renal Cell Carcinoma—A Prospective Cohort Study
(
- Contribution to journal › Article
-
Mark
European Association of Urology Guidelines on Renal Cell Carcinoma : The 2022 Update
(
- Contribution to journal › Scientific review
- 2021
-
Mark
A Decision Analysis Evaluating Screening for Kidney Cancer Using Focused Renal Ultrasound
(
- Contribution to journal › Article
-
Mark
Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?
(
- Contribution to journal › Article
-
Mark
Pattern, timing and predictors of recurrence after surgical resection of chromophobe renal cell carcinoma
(
- Contribution to journal › Article
-
Mark
The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium
(
- Contribution to journal › Article